HOME >> MEDICINE >> NEWS
Penn professor earns 2004 award from the American College of Psychiatrists

(Philadelphia, PA) -- Dwight L. Evans, MD, the Ruth Meltzer Professor and Chairman of the Department of Psychiatry at the University of Pennsylvania School of Medicine, has earned the 2004 Award for Research in Mood Disorders from the American College of Psychiatrists. This award which honors an individual or individual whose group has made major contributions to the understanding and treatment of mood disorders is presented annually. Dr. Evans was chosen from among those scholars and scientific investigators who have displayed excellence in research and who are devoted to assisting people suffering from mood disorders.

Mood disorders encompass those psychiatric disorders in which a disturbance of mood is the predominant feature, including depressive, dysthymic and bipolar disorders. These disorders affect millions of people throughout the world, can be life threatening, and result in considerable suffering and disability.

According to Dr. Evans, "Depression has become the number one cause of disability within Western Europe and North America. In the United States, approximately 20 million people suffer from serious depression and close to one million people attempt suicide each year. In this country, a person dies from suicide every 18 minutes, over 30,000 deaths each year. Further research is critical to address this worldwide public health problem."

The award, which was first given in 1998, will be presented at The College's Annual Meeting in February 2005. Dr. Evans will present a featured lecture summarizing his work. The American College of Psychiatrists is a non-profit honorary association of psychiatrists who, through excellence in their chosen fields, have been recognized for their significant contributions to the profession.


'"/>

Contact: Ed Federico
ed.federico@uphs.upenn.edu
215-662-2560
University of Pennsylvania School of Medicine
29-Dec-2004


Page: 1

Related medicine news :

1. UIC professor receives international humanitarian award
2. NJIT chemistry professor edits text outlining best laboratory practices
3. Future of clinical medicine research is at risk, warns professor
4. Employment reduces chronic drug use, UH professors find
5. Good parenting protects against chronic illness says professor of public health
6. College of Nursing professor develops videos for computers to reduce HIV sexual risk behavior
7. UGA professor receives $3 million grant from National Cancer Institute for breast cancer research
8. U-M professor to test flu shot and nasal spray flu vaccine side by side
9. Northeastern professor warns big backpacks cause big back pains
10. Tufts professor launches program to mentor deaf students in state-of-the-art physics research
11. Lifelong career adds up to top honors for UH math professor

Post Your Comments:
(Date:5/20/2013)... from Comfort & Harmony was featured at ... Association (USLCA) May 2nd – 5th. The conference hosted ... , The USLCA annual conference is a trade ... about the latest trends in lactation. , Mombo ... new mothers use to help support infants while breastfeeding. ...
(Date:5/20/2013)... 2013 Mirena IUD lawsuit ... litigation recently established in U.S. District Court, Southern District ... to court records, the litigation’s first Status Conference was ... Plaintiff’s leadership positions were discussed. So far, at ... District of New York, all of which allege that ...
(Date:5/20/2013)... 2013 Co-founder of Atlanta SEO ... keynote speaker at the 5th International INVEST Domaining & ... brings together company representatives and independent individuals from around ... marketing and investments. , The 2013 conference will take ... México from May 20 to 21. A networking city ...
(Date:5/20/2013)... Nearly 20 percent of kidneys that are recovered ... transplant due to factors ranging from scarring in small ... organ going too long without blood or oxygen. But, ... be "recycled" to help solve the critical shortage of ... Center and colleagues, reporting in the journal Biomaterials ...
(Date:5/20/2013)... 2013 Horizon NJ Health, New Jersey’s ... that it has earned a Commendable Accreditation status ... NJ Health is a wholly owned subsidiary of Horizon ... NCQA Health Plan Accreditation is a nationally recognized program ... health plans provide to their members. Health Plan Accreditation ...
Breaking Medicine News(10 mins):Health News:Comfort & Harmony™ Exhibited mombo™ Nursing Pillow at USLCA’s First Inaugural Conference 2Health News:Mirena IUD Lawsuit News: Bernstein Liebhard LLP Reports on First Status Conference in Federal Mirena Litigation 2Health News:Mirena IUD Lawsuit News: Bernstein Liebhard LLP Reports on First Status Conference in Federal Mirena Litigation 3Health News:EverSpark CEO to be Keynote Speaker at 5th International INVEST Domaining & Internet Marketing Conference in Mexico City 2Health News:Study suggests new source of kidneys for transplant 2Health News:Horizon NJ Health Awarded Commendable Accreditation by NCQA 2Health News:Horizon NJ Health Awarded Commendable Accreditation by NCQA 3
(Date:5/20/2013)... BETHESDA, Md. , May 20, 2013  TNI ... diseases through the activation and mobilization of the body,s ... trading on the OTC Markets, OTCQB marketplace under the ... able to view the real-time Level II stock quotes ... Noreen Griffin , CEO of TNI BioTech, ...
(Date:5/20/2013)... Ill. , May 20, 2013  AbbVie ... initiation of a Phase 3 clinical study called ... assess the effects of the investigational compound atrasentan - ... of kidney disease in patients with stage 2 ... 2 diabetes.  SONAR is a large, multinational, double-blind, ...
(Date:5/19/2013)... , May 20, 2013  Whole-cell pertussis vaccines were ... vaccines during a large recent outbreak, according to a ... Whole-cell pertussis vaccines, also called DTwP, were available from ... concerns that ultimately led to the development of acellular ... late 1990s, the United States ...
Breaking Medicine Technology:TNI BioTech, Inc. Stock to Begin Trading on the OTCQB Marketplace 2TNI BioTech, Inc. Stock to Begin Trading on the OTCQB Marketplace 3AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy 2AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy 3AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy 4AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy 5AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy 6Study Shows Whole-Cell Vaccine was More Effective than Acellular Vaccine During California Pertussis Outbreak 2Study Shows Whole-Cell Vaccine was More Effective than Acellular Vaccine During California Pertussis Outbreak 3Study Shows Whole-Cell Vaccine was More Effective than Acellular Vaccine During California Pertussis Outbreak 4
Cached News: